SLC6A14 (ATB0,+) Protein, a Highly Concentrative and Broad Specific Amino Acid Transporter, Is a Novel and Effective Drug Target for Treatment of Estrogen Receptor-positive Breast Cancer
Open Access
- 1 September 2011
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 286 (36), 31830-31838
- https://doi.org/10.1074/jbc.m111.229518
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancerInternational Journal of Cancer, 2010
- ATF4-dependent transcription mediates signaling of amino acid limitationTrends in Endocrinology & Metabolism, 2009
- Nutrient control of TORC1, a cell-cycle regulatorTrends in Cell Biology, 2009
- The molecular determinants of de novo nucleotide biosynthesis in cancer cellsCurrent Opinion in Genetics & Development, 2009
- A role for macroautophagy in protection against 4-hydroxytamoxifen–induced cell death and the development of antiestrogen resistanceMolecular Cancer Therapeutics, 2008
- Interaction of tryptophan derivatives with SLC6A14 (ATB0,+) reveals the potential of the transporter as a drug target for cancer chemotherapyBiochemical Journal, 2008
- Up-regulation of the amino acid transporter ATB0,+ (SLC6A14) in carcinoma of the cervixGynecologic Oncology, 2006
- Upregulation of the amino acid transporter ATB0,+ (SLC6A14) in colorectal cancer and metastasis in humansBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2005
- Transport of d-Serine via the Amino Acid Transporter ATB0,+ Expressed in the ColonBiochemical and Biophysical Research Communications, 2002
- Na+- and Cl–-coupled active transport of nitric oxide synthase inhibitors via amino acid transport system B0,+JCI Insight, 2001